2020 Revenues ($USD) : $8,945,495,411 2020 Revenues (foreign currencies) : JP¥955,200,000,000 2020 R&D spend : $1,927,327,215 2020 Number of Employees : not available Fiscal Year End : 12/31/2020 Key People : Tatsuo Higuchi, CEO; Yuko Makino, CFO
The Otsuka group's pharmaceutical business has a focus on treatments involving the central nervous system and oncology. The group is also engaged in a wide range of other fields, including cardiovascular, gastroenterology, ophthalmology, diagnostics, clinical nutrition and medical devices. The Otsuka Pharmaceutical Factory (OPF) has been in the IV business in Japan for over 70 years. –CN
Otsuka's pharmaceutical factory in Mima in Tokushima Prefecture in Japan.